Oligodendroglial response to the immune cytokine interferon gamma

Neurochemical Research

Volumn 24, Issue 2, 1999, Pages 331-338

  Popko, Brian ^a,b,c   Baerwald, Kristine D ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Curriculum in Neurobiology   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Demyelination; Experimental allergic encephalomyelitis; Interferon gamma; MHC class I; Multiple sclerosis; Oligodendrocytes; Remyelination

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MYELIN;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; BLOOD BRAIN BARRIER; CELL DEATH; IMMUNE RESPONSE; MACROPHAGE; MEDIATOR; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; T LYMPHOCYTE;

ANIMALS; DEMYELINATING DISEASES; HUMANS; INTERFERON TYPE II; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN SHEATH; OLIGODENDROGLIA;

ANIMALIA;

EID: 0032904541     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022586726510     Document Type: Article

References (97)

1. Martin, R., McFarland, H. F., and McFarlin, D. E. 1992. Immunological aspects of demyelinating diseases. Ann. Rev. Immunol. 10:153-187.
2. Raine, C. S. 1994a. The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann. Neurol. 36: S61-S72.
3. Raine, C. S. 1994b. Presidential Address: Multiple Sclerosis: Immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53:328-337.
4. Crone, C. 1986. The blood-brain barrier; a modified tight epithelium, Pages 17-40, in Suckling, A. J., Rumsby, M. G., and Bradbury, M. W. B. (eds.), The Blood-Brain Barrier in Health and Disease, Ellis Horwood, UK.
5. Poser, C. M. 1987. Trauma and multiple sclerosis. J. Neurol. 234: 155-159.
6. Poser, C. M. 1993. The pathogenesis of multiple sclerosis. Additional considerations. J. Neurol. Sci. (Suppl.) 115:S3-S15.
7. Utz, U., and McFarland, H. F. 1994. The role of T cells in multiple sclerosis: Implications for therapies targeting the T cell receptor. J. Neuropathol. Exp. Neurol. 53:351-358.
8. Booss, J., Esiri, M. M., and Tourtellotte, W. W. 1983. Immunohistochemical analysis of T-lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62:19-32.
9. Traugott, U., Reinherz, E. L., and Raine, C. S. 1983. Multiple sclerosis: Distribution of T-cell subsets within active chronic lesions. Science 219:308-310.
10. Miller, S. D., McRae, B. L., Vanderlugt, C. L., Nikcevich, K. M., Pope, J. G., Pope, L., and Karpus, W. J. 1995. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases. Immunol. Rev. 144:225-244.
11. Alvord, E. C., Jr., Kies, M. W., and Suckling, A. J. 1984. Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis, Alan R. Liss, Inc., New York.
12. Zamvil, S. S., and Steinman, L. 1990. The T lymphocyte in experimental allergic encephalomyclitis. Ann. Rev. Immunol. 8: 579-621.
13. Martin, R., and McFarland, H. F. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:121-182.
14. Voskuhl, R. R., Martin, R., Bergman, C., Calal, M., Ruddle, N. H., and McFarland, H. F. 1993. T helper 1 (TH1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15:137-143.
15. Trinchieri, G., and Perussia, B. 1985. Immune interferon: A pleiotropic lymphokine with multiple effects. Immunol. Today 6:131.
16. Farrar, M. A., and Schreiber, R. D. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11: 571-611.
17. Gray, P. W., Leung, D. W., Pennica, D., Yelverton, E., Najarian, R., Simonsen, C. C., Derynck, R., Sherwood, P. J., Wallace, D. M., Berger, S. L., Levinson, A. D., and Goeddel, D. V. 1982. Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503-508.
18. Gray, P. W., and Goeddel, D. V. 1982. Structure of the human immune interferon gene. Nature 298:859-863.
19. Gray, P. W., and Goeddel, D. V. 1983. Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 80:5842-5846.
20. Greenlund, A. C., Wenner, C. A., and Schreiber, R. D. 1992. Analysis of IFN-γ receptor binding to IFNγ. J. Interferon Res. (Abstr.) 12:S103.
21. Greenlund, A. C., Schreiber, R. D., Goeddel, D. V., and Pennica, D. 1993. Interferon-γ induces receptor dimerization in solution and on cells. J. Biol. Chem. 268:18103-18110.
22. Fountoulakis, M., Zulauf, M., Lustig, A., and Garotta, G. 1992. Stoichiometry of interaction between interferon γ and its receptor. Eur. J. Biochem. 208:781-787.
23. Bach, E. A., Tanner, J. W., Marsters, S., Ashkenazi, A., Aguet, M., Shaw, A. S., and Schreiber, R. D. 1996. Ligand-induced assembly and activation of the gamma interferon receptor in intact cells. Mol. Cell. Biol. 16:3214-3221.
24. Sadowski, H. B., Shuai, K., Darnell, J. E., Jr., and Oilman, M. Z. 1993. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739-1744.
25. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
26. Young, H. A., and Hardy, K. J. 1995. Role of interferon-γ in immune cell regulation. J. Leukoc. Biol. 58:373-381.
27. Schreiber, R. D., and Celada, A. 1985. Molecular characterization of interferon gamma as a macrophage activating factor. Lymphokines 11:87-118.
28. Swain, S. L., Bradley, L. M., Croft, M., Tonkonogy, S., Atkins, G., Weinberg, A. D., Duncan, D. D., Hedrick, S. M., Dutton, R. W., and Huston, G. 1991. Helper T-cell subsets: Phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123:115-144.
29. Gajewski, T. F., Schell, S. R., Nau, G., and Fitch, F. W. 1989. Regulation of T-cell activation: Differences among T cell subsets. Immunol. Rev. 111:79-110.
30. Snapper, C. M., and Paul, W. E. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-947.
31. Vilcek, J., Gray, P. W., Rinderknecht, E., and Sevastopoulos, C. G. 1985. Interferon gamma: a lymphokine for all seasons. Lymphokines 11:1-32.
32. Benveniste, E. N., and Benos, D. J. 1995. TNF-α- and IFN-γy-mediated signal transduction pathways: Effects on glial cell gene expression and function. FASEB J. 9:1577-1584.
33. Hartung, H. -P., Jung, S., Stoll, G., Zielasek, J., Schmidt, B., Archelos, J. J., and Toyka, K. V. 1992. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40:197-210.
34. Olsson, T. 1992. Cytokines in neuroinflammatory disease: Role of myelin autoreactive T cell production of interferon-gamma. J. Neuroimmunol. 40:211-218.
35. Panitch, H. S. 1992. Interferons in multiple sclerosis. Drugs 44: 946-962.
36. Traugott, U., and Lebon, P. 1988. Demonstration of α, β, and γ interferon in active chronic multiple sclerosis lesions. Ann. N. Y. Acad. Sci. 540:309-311.
37. Beck, J., Rondot, L., Catinot, L., Falcoff, E., Kirchner, H., and Wietzerbin, J. 1988. Increased production of interferon gamma and rumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78:318-323.
38. Renno, T., Lin, J. Y., Piccirillo, C., Antel, J., and Owens, T. 1994. Cytokine production by cells in cerebrospinal fluid during experimental allergic encephalomyelitis in SJL/J mice. J. Neuroimmunol. 49:1-7.
39. Balasingam, V., Tejada-Berges, T., Wright, E., Bouckova, R., and Yong, V. W. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14:846-856.
40. Panitch, H. S., Hirsch, R. L., Schindler, J., and Johnson, K. P. 1987. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology 37:1097-1102.
41. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., and Fathman, C. G. 1996. Mice with a disrupted interferon-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5-7.
42. Krakowski, M., and Owens, T. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641-1646.
43. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., and Ramshaw, I. A. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligo-dendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 157:3223-3227.
44. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., and Carton, H. 1988. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-γ. J. Immunol. 140:1506-1510.
45. Duong T. T., St. Louis, J., Gilbert, J. J., Finkelman, F. D., and Strejan, G. H. 1992. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 36:105-115.
46. Voorthuis, J. A. C., Uitdehaag, B. M. J., de Groot, C. J. A., Goede, P. H., van der Meide, P. H., and Dijkstra, C. D. 1990. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin. Exp. Immunol. 81:183-188.
47. Popko, B., Corbin, J. G., Baerwald, K. D., Dupree, J., and Garcia, A. M. 1997. The effects of interferon-gamma on the central nervous system. Mol. Neurobiol. 14:19-35.
48. Wong, G. H., Bartlett, P. F., Clark-Lewis, I., Battye, F., Schrader, J. W. 1984. Inducible expression of H-2 and Ia antigens on brain cells. Nature 310:688-691
49. Sethna, M. P., and Lampson, L. A. 1991. Immune modulation within the brain: Recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-gamma. J. Neuroimmunol. 34:121-132.
50. Steiniger, B., and van der Meide, P. H. 1988. Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon. J. Neuroimmunol. 19: 111-118.
51. Simmons, R. D., and Willenborg, D. O. 1990. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100:37-42.
52. Wong, D, and Dorovini-Zis, K. 1992. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39:11-21.
53. Steffen, B. J., Butcher, E. C., and Engelhardt, B. 1994. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am. J. Pathol. 145:189-201.
54. McCarron, R. M., Wang, L., Racke, M. K., McFarlin, D. E., and Spatz, M. 1993. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43:23-30.
55. Yong, V. W., Moumdjian, R., Yong, F. P., Ruijs, T. C. G., Freedman, M. S., Cashman, N., and Antel, J. P. 1991. γ-Interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc. Natl. Acad. Sci. USA 88:7016-7020.
56. Corbin, J. G., Kelly, D., Rath, E. M., Baerwald, K. D., Suzuki, K., and Popko, B. 1996. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Molec. Cell. Neurosci. 7:354-370.
57. Horwitz, M. S., Evans, C. F., McGavern, D. B., Rodriguez, M., and Oldstone, M. B. A. 1997. Primary demyelination in transgenic mice expressing interferon-gamma. Nature Med. 3:1037-1041.
58. Selmaj, K., Raine, C. S., Farooq, M., Norton, W. T., and Brosnan, C. F. 1991. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J. Immunol. 147:1522-1529.
59. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., and Lane, T. E. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:2132-2141.
60. Mitrovic, B., Ignarro, L. J., Vinters, H. V., Akers, M. A., Schmid, I., Uittenbogaart, C., and Merrill, J. E. 1995. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience 65:531-539.
61. Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., and Dietzschold, B. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90:3024-3027.
62. Bö, L., Dawson, T. M., Wesselingh, S., Mörk, S., Choi, S., Kong, P. A., Hanley, D., and Trapp, B. D. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778-786.
63. Vartanian, T., Li, Y., Zhao, M., and Stefansson, K. 1995. Interferon-γ-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Molec. Med. 1:732-743.
64. Agresti, C., D'Urso, D., and Levi, G. 1996. Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 8:1106-1116.
65. Turnley, A. M., Miller, J. F. A. P., and Bartlett, P. F. 1991a. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-γ and TNF-α. Neurosci. Lett. 123:45-48.
66. Baerwald, K. D., and Popko, B. 1998. Developing and mature oligodendrocytes respond differently to the immune cytokine interferon-gamma. J. Neurosci. Res. 52:230-239.
67. Ozawa, K., Suchanek, G., Breitschopf, H., Bruck, W., Budka, H., Jellinger, K., and Lassmann, H. 1994. Patterns on oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322.
68. Prineas, J. W. 1975. Pathology of the early lesion in multiple sclerosis. Hum. Pathol. 6:531-554.
69. Abramsky, O. 1982. Oligodendrocytes: the putative target cells of multiple sclerosis. Is. J. Med. Sci. 18:149-158.
70. Bartlett, P. F., and MacKay, I. R. 1983. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis. J. Clin. Lab. Immunol. 11:1-7.
71. Prineas, J. W. 1985. The neuropathology of multiple sclerosis. Pages 213-257, in Koetsier, J. D. (ed.), Handbook of Clinical Neurology, Elsevier Science, Amsterdam.
72. Rodriguez, M., and Scheithauer, B. 1994. Ultrastructure of multiple sclerosis. Ultrastructural Pathol. 18:3-13.
73. Suzumura, A., Silberberg, D. H., and Lisak, R. P. 1986. The expression of MHC antigens on oligodendrocytes: Induction of polymorphic H-2 expression by lymphokines. J. Neuroimmunol. 11: 179-190.
74. Calder, V. L., Wolswijk, G., and Noble, M. 1988. The differentiation of 0-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens. Eur. J. Immunol. 18: 1195-1201.
75. Satoh, J., Kim, S. U., Kastrukoff, L. F., and Takei, F. 1991. Expression and induction of intercellular adhesion molecules (ICAMs) and major histocompatibility complex (MHC) antigens on cultured murine oligodendrocytes and astrocytes. J. Neurosci. Res. 29:1-12.
76. Massa, P. T., Ozato, K., and McFarlin, D. E. 1993. Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8:201-207.
77. Li, Y., Atashi, J., Hayes, C., Reap, E., Hunt, III, D., and Popko, B. 1995. Morphological and molecular response of the MOCH-1 oligodendrocyte cell line to serum and interferon-γ: Possible implications for demyelinating disorders. J. Neurosci. Res. 40:189-198.
78. Turnley, A. M., Morahan, G., Okano, H., Bernard, O., Mikoshiba, K., Allison, J., Bartlett, P. F., and Miller, J. F. A. P. 1991. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (Lond.) 353:566-568.
79. Yoshioka, T., Feigenbaum, L., and Jay, G. 1991. Transgenic mouse model for central nervous system demyelination. Mol. Cell. Biol. 11:5479-5486.
80. Gow, A., Friedrich, V. L., Jr., and Lazzarini, R. A. 1994. Many naturally occurring mutations of myelin proteolipid protein impair its intracellular transport. J. Neurosci. Res. 37:574-583.
81. Skoff, R. P. 1995. Programmed cell death in the dysmyelinating mutants. Brain Pathol. 5:283-288.
82. Gow, A., and Lazzarini, R. A. 1996. A cellular mechanism governing the severity of Pelizaeus-Marzbacher disease. Nature Genet. 13:422-128.
83. Tosic, M., Gow, A., Dolivo, M., Domanska-Janik, K., Lazzarini, R. A., and Matthieu, J.-M. 1996. Proteolipid/DM-20 proteins bearing the paralytic tremor mutation in peripheral nerves and transfected Cos-7 cells. Neurochem. Res. 21:423-430.
84. Gow, A., Southwood, C. M., and Lazzarini, R. A. 1998. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J. Cell Biol. 140:925-934.
85. Readhead, C., Schneider, A., Griffiths, I., and Nave, K.-A. 1994. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
86. Kagawa, T., Ikenaka, K., Inove, Y., Kuriyama, S., Tsujii, T., Nakao, J., Nakajima, K., Aruga, J., Okano, H., and Mikoshiba, K. 1994. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13: 427-442.
87. Magyar, J. P., Martini, R., Ruelicke, T., Aguzzi, A., Adlkofer, K., Dembic, Z., Zielasek, J., Toyka, K. V., and Suter, U. 1996. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16:5351-5360.
88. D'Urso, D., Prior, R., Greiner-Petter, R., Gabreëls-Festen, A. A. W. M., and Müller, H. W. 1998. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J. Neurosci. 18:731-740.
89. Power, C., Kong, P.-A., and Trapp, B. D. 1996. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J. Neurosci. Res. 44:165-173.
90. Somlyo, A. P., and Somlyo, A. V. 1986. Electron probe analysis of calcium content and movements in sarcoplasmic reticulum, endoplasmic reticulum, mitochondria, and cytoplasm. J. Cardiovasc. Pharmacol. 8:S42-S47.
91. Pahl, H. L., and Baeuerle, P. A. 1997. The ER-overload response: Activation of NF-κB. TIBS 22:63-67.
92. Benjamins, J. A., and Nedelkoska, L. 1996, Release of intracellular calcium stores leads to retraction of membrane sheets and cell death in mature mouse oligodendrocytes. Neurochem. Res. 21:471-479.
93. Dubois-Dalcq, M., and Armstrong, R. 1990. The cellular and molecular events of central nervous system remyelination. Bioessays 12:569-576.
94. Rodriguez, M., Scheithauer, B. W., Forbes, G., and Kelly, P. J. 1993. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clinic Proc. 68:627-636.
95. Rodriguez, M., and Miller, D. J. 1994. Immune promotion of central nervous system remyelination. Prog. Brain Res. 103:343-355.
96. Armstrong, R., Friedrich, V. L., Jr., Holmes, K. V., and Dubois-Dalcq, M. 1990. In vitro analysis of the oligodendrocyte lineage in mice during demyelination and remyelination. J. Cell Biol. 111: 1183-1195.
97. Carrol, W. M., and Jennings, A. R. 1994. Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 117: 563-578.